Percutaneous coronary interventions for stable ischemic heart disease in Italy

Stefano De Servi1, Zoran Olivari2, Gabriele Crimi3

  • 1Unita' di Cardiologia, IRCCS MultiMedica, Milan.

Insights

Percutaneous coronary interventions (PCIs) for stable chronic ischemic heart disease (SIHD) are common in Italy, with significant regional differences. Increased use of fractional flow reserve (FFR) and Heart Team assessments correlate with fewer ad-hoc PCIs.

Area of Science:

  • Cardiology
  • Interventional Cardiology
  • Public Health

Background:

  • Percutaneous coronary interventions (PCIs) for stable chronic ischemic heart disease (SIHD) are frequently performed, often without physiologic guidance like fractional flow reserve (FFR).
  • The benefits of PCI in SIHD remain controversial, yet utilization is high.
  • Significant regional variations in PCI practices exist within Italy.

Purpose of the Study:

  • To assess regional variations in PCI for SIHD in Italy.
  • To investigate the correlation between PCI rates and the utilization of FFR.
  • To evaluate the impact of mandated Heart Team assessments on ad-hoc PCI procedures.

Main Methods:

  • Analysis of the Italian Society of Interventional Cardiology (SICI-GISE) registry data for 2017.
  • Correlation of regional PCI per million inhabitants with FFR usage.
  • Comparison of ad-hoc PCI rates in regions with and without mandated Heart Team reviews.

Main Results:

  • PCI for SIHD constituted 44.5% of all PCIs in Italy, with substantial regional disparities.
  • A significant inverse relationship was observed between FFR use and the number of SIHD PCIs per capita (P=0.01).
  • The Veneto region, with mandated Heart Team assessments, showed a lower rate of ad-hoc procedures than the national average.

Conclusions:

  • PCI for SIHD represents a significant proportion of procedures in Italy, exhibiting regional variability linked to the use of physiologic guidance.
  • Mandatory Heart Team evaluation for multivessel disease patients is associated with a reduction in ad-hoc PCI procedures.
  • These findings highlight the importance of structured decision-making processes and physiologic guidance in optimizing PCI utilization for SIHD.
Abstract

Related Concept Videos

Ischemic Heart Disease: Overview01:17

Ischemic Heart Disease: Overview

Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
3.0K
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
909
Heart Failure VII: Nursing Interventions01:30

Heart Failure VII: Nursing Interventions

The first step in nursing management of a patient with heart failure involves thoroughly assessing the patient's medical history.Subjective Data: Obtain the patient's medical history of coronary artery disease, hypertension, myocardial infarction, and symptoms like dyspnea, orthopnea, and paroxysmal nocturnal dyspnea.Objective Data: Conduct a physical examination to identify findings such as jugular vein distention, pulmonary crackles, tachycardia, murmurs, peripheral edema, and vital signs,...
436
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
387
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
220
Rheumatic Heart Disease I: Introduction01:23

Rheumatic Heart Disease I: Introduction

Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
455